Founded in 2007 in Delaware and headquartered in North Billerica, Massachusetts, Lantheus Holdings, Inc. is a global leader in the development, production, sales, and distribution of innovative diagnostic imaging agents and products designed to assist clinicians in diagnosing cardiovascular and other diseases. The company's agents are commonly used in the diagnosis of conditions such as coronary artery disease, congestive heart failure, stroke, peripheral vascular disease, and more. Clinicians employ Lantheus’s imaging agents and products across a range of modalities—including nuclear imaging, echocardiography, and magnetic resonance imaging—to provide critical diagnostic insight. Lantheus is committed to delivering improved diagnostic information that enables healthcare providers to better detect, characterize, or rule out disease, ultimately aiming to enhance patient outcomes, reduce risks, and help contain overall costs to taxpayers and the healthcare system. For more information, visit their website at http://www.lantheus.com. The company’s address is 201 Burlington Road, South Building, Bedford, MA 01730.

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for LNTH via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.